Animal models of type 2 diabetes exhibit reduced peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) mRNA levels, which are associated with decreased oxidative capacity, in skeletal muscles. In contrast, animal models with metabolic syndrome show normal PGC-1α mRNA levels. We hypothesized that a high-fat diet decreases PGC-1α mRNA levels in skeletal muscles of rats with metabolic syndrome, reducing muscle oxidative capacity and accelerating metabolic syndrome or inducing type 2 diabetes. We examined mRNA levels and fiber profiles in the soleus muscles of rats with metabolic syndrome (SHR/NDmcr-cp [cp/cp], CP) fed a high-fat diet. Five-week-old CP rats were assigned to a sedentary group (CP-N) that was fed a standard diet (3.60 kcal/g, 23.6% protein, 5.3% fat, and 54.4% carbohydrates) or a sedentary group (CP-H) that was fed a high-fat diet (5.16 kcal/g, 23.6% protein, 34.9% fat, and 25.9% carbohydrates) and were housed for 10 weeks.
Introduction
Metabolic syndrome is characterized by obesity, high blood pressure, increased glucose levels, and dyslipidemia [1] . Skeletal muscle is the major site of insulin action and glucose metabolism. Reduced oxidative capacity in the skeletal muscles of humans and animal models with metabolic syndrome is known to impair glucose metabolism and increase the risk of the development of lifestyle-related disease, for example, type 2 diabetes and its complications [2] . The skeletal muscles of patients with type 2 diabetes exhibit a lower percentage of high-oxidative fibers than those of healthy individuals [3] [4] [5] [6] . Similarly, the skeletal muscles of rats with type 2 diabetes have a lower oxidative capacity and contain a lower percentage of high-oxidative fibers than those of nondiabetic rats [7] [8] [9] [10] . These results indicate that type 2 diabetes is associated with reduced oxidative capacity in skeletal muscles.
Previous studies [11] [12] [13] [14] [15] [16] have established that nuclear receptors such as peroxisome proliferator-activated receptors (PPARs) and estrogen-related receptors (ERRs), along with the coregulator PPAR coactivator-1α (PGC-1α), control diverse aspects of aerobic metabolism, including fatty acid oxidation, oxidative phosphorylation, and mitochondrial biogenesis, in skeletal muscles. The properties of skeletal muscle fibers, including type distribution and oxidative enzyme activity, are regulated by PGC-1α [11] [12] [13] . Our previous studies [14, 15] showed that rats with type 2 diabetes have lower PGC-1α mRNA levels in the slow soleus and fast plantaris muscles than nondiabetic rats. Therefore, we concluded that reduced PGC-1α mRNA levels in the skeletal muscles of rats with type 2 diabetes are associated with a low percentage of high-oxidative fibers. ERRγ, which is a constitutively active orphan nuclear receptor, is highly expressed in tissues with high metabolic activity, for example, heart, kidney, brown adipose tissue, and skeletal muscle, especially the slow muscle [16] . ERRγ regulates mitochondria, increasing the number of mitochondria and their oxidative capacity in skeletal muscles by mediating the action of PGC-1α.
We hypothesized that a high-fat diet decreases PGC-1α mRNA levels in the skeletal muscles of humans and animal models with metabolic syndrome, reducing muscle oxidative capacity. If this is true, the risk of inducing lifestyle-related diseases would be higher when humans and animal models with metabolic syndrome continuously consume a high-fat diet.
In the present study, we examined the mRNA levels of genes related to glucose and lipid metabolism and fiber profiles, including type distribution, cross-sectional area, and oxidative enzyme activity, in the soleus muscles of rats with metabolic syndrome that were fed a 4 high-fat diet. We used SHR/NDmcr-cp [cp/cp] (CP) rats as an animal model of metabolic syndrome. CP rats have a nonsense mutation in the leptin receptor gene [17, 18] and develop obesity, high blood pressure, increased glucose levels, hyperinsulinemia, and dyslipidemia as adults.
Methods and materials

Animals and experimental procedures
All experimental procedures and animal care were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institute of Health. This study was approved by the Institutional Animal Care and Experiment Committee of Kyoto University (Kyoto, Japan).
Five-week-old male CP rats were divided into 2 groups: sedentary, fed a standard diet (CP-N; n = 6) and sedentary, fed a high-fat diet (CP-H; n = 6). Age-matched male Wistar-Kyoto rats fed a standard diet were used as nonobese controls (WKY; n = 6). All rats were obtained from Japan SLC Inc. (Hamamatsu, Japan). The nonpurified standard diet comprised 23.6% protein, 5.3% fat, and 54.4% carbohydrates and provided 3.6 kcal/g (MF;
Oriental Yeast Co. Ltd., Tokyo, Japan), while the high-fat diet comprised 23.6% protein, 34 .9% fat, and 25.9% carbohydrates and provided 5.16 kcal/g (Test Diet 58Y1, rodent purified diet with 60% energy from fat; PMI Nutrition International, Richmond, IN). Food and water were provided ad libitum, and the food and caloric intakes of each rat were measured daily (every 24 h). All rats were housed in individual, uniformly sized standard cages. The room was maintained under a controlled 12-h light/dark cycle (lights were on from 08:00 to 20:00 h) at 22 ± 2°C with 45-55% relative humidity. Body weight and systolic and diastolic blood pressures of rats in all groups were measured at 5, 7, 9, 11, 13, and 15 weeks of age. Systolic and diastolic blood pressures were determined automatically in conscious rats using the indirect tail-cuff method with a BP-98A sphygmomanometer (Softron Inc., Tokyo, Japan).
Blood glucose analysis
Fasting glucose levels were measured at 5, 7, 9, 11, 13 , and 15 weeks of age after a 15-h fast. Blood samples were obtained from the tail veins of fully conscious rats and were analyzed using a portable glucose meter (GT-1650; Arkray Inc., Kyoto, Japan). Nonfasting 5 glucose levels were also measured at 15 weeks of age using the same glucose meter.
Serum biochemical measurements
All rats at 15 weeks of age were fasted for 15 h before blood sampling. Blood samples were obtained from the abdominal aorta under pentobarbital sodium anesthesia (5 mg/100 g body weight, i.p.). Serum triglyceride and total cholesterol levels were measured by routine laboratory methods. Serum insulin, leptin, and high molecular-weight adiponectin levels were measured using enzyme-linked immunosorbent assay (ELISA) kits for rats (Shibayagi Co.
Ltd., Shibukawa, Japan).
Biochemical analysis of the muscle
The soleus muscles of both legs were dissected, and the muscle wet weight was measured. After muscle dissection, the rats were killed by overdose of pentobarbital sodium. 
Analysis of mRNA expression in the muscle
Total RNA was extracted from the left soleus muscle using TRIzol Reagent (Invitrogen, Carlsbad, CA) and then treating samples with deoxyribonuclease I (Invitrogen). The first strand of cDNA was synthesized from 1.0 µg of total RNA using the PrimeScript RT reagent kit (Takara Bio Inc., Otsu, Japan). We analyzed gene expression by real-time polymerase chain reaction (RT-PCR) using a LightCycler DX400 system (Roche Diagnostics, Mannheim, Germany) with SYBR Premix Ex Taq II (Takara Bio Inc.). The mRNA levels of PPARδ/β, PGC-1α, stearoyl-CoA desaturase-1 (SCD-1), and glucose transporter 4 (GLUT4) were 6 normalized to hypoxanthine phosphoribosyltransferase (HPRT) mRNA expression. The primer sets for PPARδ/β, PGC-1α, and SCD-1 were described previously [14, 15] . GLUT4 primers were as follows: forward, 5′-CAACTGGACCTGTAACTTCATCGT-3′ and reverse: 5′-ACGGCAAATAGAAGGAAGACGTA-3′.
Histochemical analysis of muscle tissues
The proximal part of the right soleus muscle was pinned to a corkboard and rapidly frozen in isopentane cooled with a mixture of dry ice and acetone. The muscle was mounted on a specimen chuck with Tissue-Tek OCT compound (Sakura Finetechnical Co. Ltd., Tokyo, Japan). Serial transverse 10-μm thick sections were cut using a cryostat at -20°C. Different fiber types were classified on the basis of ATPase activity [20] . The sections were allowed to reach room temperature, air dried for 30 min, and pre-incubated in alkaline (pH 10. The sections were also stained for 10 min to quantify SDH intensity [20] . SDH intensity was quantified for approximately 500 fibers described above using a computer-assisted image processing system (Neuroimaging System Inc.). Sectional images were digitized as gray scale images. Each pixel was quantified as one of 256 gray levels: gray level 0 was equivalent to 100% light transmission and gray level 255 was equivalent to 0% light transmission. The mean optical density (OD) of all pixels (which were converted to gray level values) within a fiber was determined using a calibration photographic tablet with 21 steps of gradient-density ranges and corresponding diffused density values. 7
Statistical analyses
All measured values are presented as mean and standard deviation. One-way analysis of variance (ANOVA) was used to evaluate mean differences among the age-matched groups.
When the differences were found to be significant by ANOVA, further comparisons were made using Scheffé's post hoc test. A probability level of 0.05 was accepted as significant.
Results
Body weight
Body weight at 11-15 weeks was higher in the CP-N group than in the age-matched WKY group (Fig. 1A) . Body weight at 7 weeks was higher in the CP-H group than in the age-matched WKY group. Furthermore, body weight at 9-15 weeks was higher in the CP-H group than in the age-matched WKY and CP-N groups. 
Food and caloric intake
Food intake at 5-7 weeks was higher in the CP-N group than in the age-matched WKY and CP-H groups (Fig. 1B) . Food intake at 9-15 weeks was higher in the CP-N group than in the age-matched WKY group. Food intake at 5-15 weeks was higher in the CP-H group than in the age-matched WKY group.
Caloric intake at 5-15 weeks was higher in the CP-N group than in the age-matched WKY group (Fig. 1C) . Caloric intake at 5-9 weeks was higher in the CP-H group than in the age-matched WKY group. Furthermore, caloric intake at 11-15 weeks was higher in the CP-H group than in the age-matched WKY and CP-N groups. 
Blood pressure
Systolic blood pressure at 9-15 weeks was higher in the CP-N group than in the age-matched WKY group (Fig. 1D) . Systolic blood pressure at 5-13 weeks was higher in the CP-H group than in the age-matched WKY group. Furthermore, systolic blood pressure at 15 weeks was higher in the CP-H group than in the age-matched WKY and CP-N groups.
Diastolic blood pressure at 11-15 weeks was higher in the CP-N group than in the age-matched WKY group (Fig. 1E) . Diastolic blood pressure at 9-15 weeks was higher in the CP-H group than in the age-matched WKY group.
Blood glucose levels
Fasting glucose levels at 5-7 weeks were higher in the CP-N and CP-H groups than in the age-matched WKY group (Fig. 1F ). Nonfasting glucose levels at 15 weeks were higher in the CP-N group than in the age-matched WKY group ( Fig. 2A ). Nonfasting glucose levels at 15 weeks were higher in the CP-H group than in the age-matched WKY and CP-N groups. 
Serum biochemical parameters
Triglyceride (Fig. 2B ) and leptin ( Fig. 2E ) levels were higher in the CP-N group than in the WKY group. Triglyceride and leptin levels were higher in the CP-H group than in the WKY and CP-N groups. Total cholesterol levels were higher in the CP-H group than in the WKY and CP-N groups (Fig. 2C ). Insulin levels were higher ( Fig. 2D ) and adiponectin levels were lower (Fig. 2F ) in the CP-N and CP-H groups than in the WKY group.
Soleus muscle weight and SDH activity
Muscle weight was lower in the CP-N and CP-H groups than in the WKY group (Fig. 3A) .
Muscle SDH activity was lower in the CP-N group than in the WKY group (Fig. 3B ). Muscle SDH activity was lower in the CP-H group than in the WKY and CP-N groups. 
Soleus muscle mRNA levels
PPARδ/β mRNA levels were lower ( Fig. 3C ) and the SCD-1 mRNA levels were higher ( Fig. 3E ) in the CP-N and CP-H groups than in the WKY group. PGC-1α mRNA levels were lower in the CP-H group than in the WKY and CP-N groups (Fig. 3D ). GLUT4 mRNA levels were lower in the CP-H group than in the WKY group (Fig. 3F ). 
Soleus muscle fiber profiles
Muscles in the WKY, CP-N, and CP-H groups contained 3 types of fibers: type I, IIA, and IIC (Fig. 4) . Percentage of type I fibers was lower while percentage of type IIA fibers 10 was higher in the CP-N and CP-H groups than in the WKY group (Fig. 3G ). Cross-sectional areas of type I, IIA, and IIC fibers were lower in the CP-N and CP-H groups than in the WKY group (Fig. 3H ). SDH intensity of type IIA fibers was lower in the CP-N and CP-H groups than in the WKY group (Fig. 3I ).
Discussion
Animal model of metabolic syndrome
Metabolic syndrome is characterized by obesity, high blood pressure, increased glucose levels, and dyslipidemia [1] . In the present study, CP rats with metabolic syndrome (CP-N and CP-H) showed greater body weight (Fig. 1A) , higher systolic ( Fig. 1D ) and diastolic ( Fig. 1E ) blood pressures, and increased nonfasting glucose ( Fig. 2A) and triglyceride (Fig.   2B ) levels than normal rats (WKY). Furthermore, CP rats exhibited a lower soleus muscle weight than WKY rats (Fig. 3A) . It is likely that the decreased soleus muscle weight of CP rats was due to atrophy of all types of muscle fibers (Fig. 3H ). Although we did not measure the spontaneous motor activities of individual rats in the present study, this type of atrophy is known to be associated with the lower motor activity levels induced by obesity. The soleus muscle is an antigravity muscle that is persistently active; therefore, the fiber sizes are more susceptible to decreased muscle activity and loading levels. Our previous study [14] observed that CP rats were inactive in their cages all day long, except when they ate, probably due to their excess body weight.
PPARδ/β is the main transcription factor that regulates fatty acid oxidation in skeletal muscle and adipose tissue and activates lipid metabolism to prevent obesity [21] . The reduced PPARδ/β mRNA levels in the skeletal muscles of CP (CP-N and CP-H) rats (Fig. 3C ) may have induced a decreased capacity for fatty acid oxidation. A previous study [22] showed that hypertriglyceridemia and hyperinsulinemia were associated with increased SCD-1 activity. Therefore, the hypertriglyceridemia (Fig. 2B) and hyperinsulinemia (Fig. 2D ) observed in CP rats may be associated with the increase in SCD-1 mRNA levels (Fig. 3E) , which were 8.7and 7.5-fold higher in CP-N and CP-H rats than in WKY rats, respectively.
Effects of a high-fat diet on metabolic syndrome
In rats, a high-fat diet stimulates tyrosine-kinase activity and reduces autophosphorylation of the β-subunit of the insulin receptor in the liver [23] [24] [25] .
Furthermore, in vitro exposure of isolated hepatocytes to free fatty acids causes a dose-dependent decrease in cell-surface insulin receptor binding along with diminished receptor-mediated internalization and degradation [24, 26] . A reduction in insulin action in the liver leads to decreased inhibition of hepatic glucose output. On the other hand, the oxidative stress pathway responsible for the production of reactive oxygen species is upregulated in both liver and adipose tissue of mice fed a high-fat diet before the onset of insulin resistance and obesity [27] . These results indicate that liver and adipose tissue are important in the maintenance of glucose and lipid metabolism and that a condition of excessive nutrient intake induces and accelerates insulin resistance and enhances oxidative stress levels. Insulin resistance has been recognized as the integral feature of metabolic syndrome, which includes glucose intolerance, hypertriglyceridemia, low HDL-cholesterol, and hypertension. In the present study, we investigated PGC-1α mRNA levels and oxidative capacity of the soleus muscles in rats with metabolic syndrome because a high-fat diet may have significant effects on the skeletal muscles of rats with metabolic syndrome as well as on liver and adipose tissue.
In CP (CP-N and CP-H) rats, CP-H rats exhibited a greater body weight (Fig. 1A) , higher systolic blood pressure (Fig. 1D) , and increased nonfasting glucose ( Fig. 2A) and triglyceride ( Fig. 2B ) levels than CP-N rats, while there was no difference in insulin levels between CP-N and CP-H rats (Fig. 2D) . The insulin signaling pathway may be downregulated in CP-H rats, and decreased phosphorylation of the insulin receptor and insulin receptor substrate (IRS)-1 may be present, although this was not investigated in the present study. These results indicate that a high-fat diet accelerates metabolic syndrome. Insulin and leptin stimulate the sympathetic nervous system, and this contributes to increased blood pressure [28] . CP-H rats had higher systolic blood pressure ( Fig. 1D ) and leptin levels ( Fig. 2E ) than CP-N rats, suggesting that the increased leptin levels in CP-H rats may contribute to higher blood pressure.
In the present study, CP-H rats showed higher insulin levels than WKY rats ( Fig. 2D ), suggesting that these rats were still able to produce insulin at this stage. However, continuation of increased caloric intake under the influence of metabolic syndrome may have resulted in decreased insulin levels because the pancreas may have exhausted its ability to produce the large amounts of insulin required for continued hyperinsulinemia. This decrease in insulin levels would eventually lead to the development of type 2 diabetes.
ERRγ is exclusively expressed in the slow muscle [16] , indicating that there is an ERRγ pathway that promotes and coordinates vascular supply and metabolic demand in the slow muscle. In a previous study [29] , mice that transgenically overexpressed ERRγ in the fast muscle exhibited high running endurance, resistance to diet-induced weight gain, increased oxygen consumption, enhanced oxidative capacity, dense vasculature, and increased expression of genes promoting fat metabolism, mitochondrial respiration, and high-oxidative fiber specification. These results indicate that transgenic expression of ERRγ in the fast muscle triggers an anaerobic to aerobic transformation and vascular remodeling to enhance aerobic capacity. In addition, the intrinsic effects of ERRγ do not depend on PGC-1α induction, but rather are associated with ERRγ-directed adenosine monophosphate-activated protein kinase (AMPK) activation in skeletal muscles [29] .
Multiple diseases, including metabolic syndrome and type 2 diabetes, are commonly linked to deregulation of both oxidative metabolism and vascularity. In skeletal muscles, oxidative capacity is an important factor influencing the progression or prevention of lifestyle-related diseases, for example, type 2 diabetes [14, 15] . In the present study, we focused on PGC-1α mRNA levels and oxidative capacity in the skeletal muscles of rats with metabolic syndrome fed a high-fat diet. A previous study [11] observed that PGC-1α mRNA levels in skeletal muscles were associated with oxidative capacity; enhanced PGC-1α mRNA levels induced an increased percentage of high-oxidative fibers in skeletal muscles, while reduced PGC-1α mRNA levels induced a decreased percentage of high-oxidative fibers. In our previous studies [14, 15] , we observed that the slow soleus and fast plantaris muscles of rats with type 2 diabetes exhibited lower PGC-1α mRNA levels than normal rats and rats with metabolic syndrome, whereas there were no differences in PGC-1α mRNA levels in the skeletal muscles of normal rats and rats with metabolic syndrome. These results indicated that rats with metabolic syndrome maintain normal PGC-1α mRNA levels, while those with type 2 diabetes show reduced PGC-1α mRNA levels, inducing decreased muscle oxidative capacity. In the present study, we hypothesized that a high-fat diet induces the decrease in PGC-1α mRNA levels in the skeletal muscles of animal models with metabolic syndrome, leading to reduced muscle oxidative capacity. Our present data support this hypothesis; decreased PGC-1α mRNA levels ( Fig. 3D ) and reduced oxidative enzyme activity (Fig. 3B) were observed in the soleus muscles of CP-H rats compared with those of CP-N rats.
Limitations of the present study
In the present study, we used CP rats having a nonsense mutation in the leptin receptor [17, 18] . The results obtained by this animal model cannot be directly applied to humans, although profiles of metabolic syndrome, for example, obesity, high blood pressure, increased glucose levels, and dyslipidemia, are similar in CP rats and humans.
Although previous investigations using several animal models have studied the traditional high-fat diet in animal models of diet-induced obesity, comparison of this high-fat diet to diets consisting of food regularly consumed by humans, including high-salt, high-fat, low-fiber, and energy dense foods, are lacking. In the "cafeteria diet" model [30, 31] , animal are allowed free access to standard chow and water while highly palatable, energy-dense, and unhealthy human foods are offered concurrently. This diet promotes rapid weight gain, increased fat mass, and enhanced prediabetic parameters, including glucose and insulin intolerance [32] [33] [34] . Since diet-induced obesity in animal models is a commonly used tool to support clinical research in humans, further experiments using an alternative dietary model of energy-dense and highly palatable cafeteria-style foods in animal models would be useful.
In conclusion, while the development and progression of metabolic syndrome depends on genetic background, it is also highly influenced by daily lifestyle. Increased energy intake is the major cause of decreased PGC-1α mRNA levels and oxidative capacity in skeletal muscles, and this accelerates metabolic syndrome and eventually induces type 2 diabetes.
